Nitric oxide-mediated vasorelaxation induced by sodium polyoxyethylene laurylether sulfate

被引:5
作者
Koyama, K [1 ]
Kasuya, Y [1 ]
Koyama, K [1 ]
Goto, K [1 ]
机构
[1] UNIV TSUKUBA,INST BASIC MED SCI,DEPT PHARMACOL,TSUKUBA,IBARAKI 305,JAPAN
关键词
D O I
10.1006/taap.1997.8192
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ingestion of surfactants is known to cause hemodynamic changes with decreased total vascular resistance. Motivated by this clinical observation, we investigated the direct effects of a common anionic surfactant, sodium polyoxyethylene laurylether sulfate (LES), on isolated ring segments of rat thoracic aorta, LES did not produce any vasocontractile responses, but relaxed ring segments precontracted with 10(-6) M phenylephrine in a concentration-dependent manner. This LES-induced vasorelaxation was significantly reduced by the removal of endothelium or pretreatment with N-G-nitro-L-arginine methylester hydrochloride, methylene blue, or oxyhemoglobin to the same degree, but was not affected by pretreatment with indomethacin. A further study measuring NO2- plus NO3- (NOx, total metabolites of NO) in the medium of calf pulmonary artery endothelial (CPAE) cells, a cultured cell line, revealed that LES caused a significant increase in NOx production. On the other hand, in a study measuring intracellular Ca2+ in fura-2-loaded CPAE cells, LES caused a significant increase in intracellular Ca2+, These results suggest that LES causes endothelium-dependent vasorelaxation via a NO-mediated signaling pathway, which might be due to Ca2+ mobilization, (C) 1997 Academic Press.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 36 条
[21]   ENDOTHELIAL CGMP DOES NOT REGULATE BASAL RELEASE OF ENDOTHELIUM-DERIVED RELAXING FACTOR IN CULTURE [J].
MARCZIN, N ;
RYAN, US ;
CATRAVAS, JD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01) :L113-L121
[22]  
MARTIN W, 1985, J PHARMACOL EXP THER, V232, P708
[23]   BIOSYNTHESIS OF ENDOTHELIUM-DERIVED RELAXING FACTOR - A CYTOSOLIC ENZYME IN PORCINE AORTIC ENDOTHELIAL-CELLS CA-2+-DEPENDENTLY CONVERTS L-ARGININE INTO AN ACTIVATOR OF SOLUBLE GUANYLYL CYCLASE [J].
MAYER, B ;
SCHMIDT, K ;
HUMBERT, P ;
BOHME, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (02) :678-685
[24]   L-NG-NITRO ARGININE (L-NOARG), A NOVEL, L-ARGININE-REVERSIBLE INHIBITOR OF ENDOTHELIUM-DEPENDENT VASODILATATION INVITRO [J].
MOORE, PK ;
ALSWAYEH, OA ;
CHONG, NWS ;
EVANS, RA ;
GIBSON, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (02) :408-412
[25]  
NOGUCHI S, 1995, J JPN SOC INTENSIVE, V2, pS156
[26]   A NOVEL IN-VIVO ASSAY SYSTEM FOR CONSECUTIVE MEASUREMENT OF BRAIN NITRIC-OXIDE PRODUCTION COMBINED WITH THE MICRODIALYSIS TECHNIQUE [J].
OHTA, K ;
ARAKI, N ;
SHIBATA, M ;
HAMADA, J ;
KOMATSUMOTO, S ;
SHIMAZU, K ;
FUKUUCHI, Y .
NEUROSCIENCE LETTERS, 1994, 176 (02) :165-168
[27]   NITRIC-OXIDE RELEASE ACCOUNTS FOR THE BIOLOGICAL-ACTIVITY OF ENDOTHELIUM-DERIVED RELAXING FACTOR [J].
PALMER, RMJ ;
FERRIGE, AG ;
MONCADA, S .
NATURE, 1987, 327 (6122) :524-526
[28]   CHARACTERIZATION OF 3 INHIBITORS OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE INVITRO AND INVIVO [J].
REES, DD ;
PALMER, RMJ ;
SCHULZ, R ;
HODSON, HF ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) :746-752
[29]   LYSOLECITHINS AS ENDOTHELIUM-DEPENDENT VASCULAR SMOOTH-MUSCLE RELAXANTS THAT DIFFER FROM ENDOTHELIUM-DERIVED RELAXING FACTOR (NITRIC-OXIDE) [J].
SAITO, T ;
WOLF, A ;
MENON, NK ;
SAEED, M ;
BING, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) :8246-8250
[30]  
SAWADA Y, 1988, JPN J ACUTE MED, V12, P1413